Episodes: 28
Frequency: Irregular
Rating: 5.0/5.0
Estimated listeners: 100 - 1,000
Gender skew: Male
Listener location: USA
Publicly listed emails
raisingbiotech@gmail.com
sfernando.journalist@gmail.com
Looking for the right person? Join Podseeker to find direct host and producer contacts and manage your podcast outreach.
Surani Fernando - Journalist Surani Fernando hosts Raising Biotech. The show goes beyond headlines to explore how biotech companies are built—from bold ideas and fundraises to the science that could reshape healthca...
Dr Jakob Dupont - Investor Perspective On Biotech Evaluation; Unmet Need, Clinical Strategy; Sofinnova’s Approach To Clinical-stage Investing; Examples From Portfolio; Ai-enabled Drug Development And Accelerating Development
Prof David Nutt - Science Of Psychedelic Medicine; Regulatory Concerns; Skepticism And Implementation Complexities For Psychedelics
Kabir Nath - Compass Origin Story And Financing; Institutional Interest; Phase Ii/phase III Progress; Psychedelics Regulatory And Implementation Challenges
William Ho - Hype Cycles And Long-term Unknowns; Investor Framing And The Risks/unknowns Behind Glp-1 Momentum
Stephanie Sirota - Investor Vantage Point On Glp-1 Capital Flows; Framing Glp-1s Beyond Weight Loss; Challenges For Complex Biotech Raising
S4, E8: Infinimmune – From a Scientific Hunch to an $838M Merck Partnership, with CEO and co-founder Wyatt McDonnell
September 03, 2026
In this episode, Surani explores the unconventional start-up story of Infinimmune, an antibody discovery company founded in 2022 by five former 10x Genomics scientists. Starting with a scientific hunch that advances in single-cell sequencing were revealing previously overlooked antibody biology, the team went from debating ideas in a tiny California office to raising a $12 million seed round in just three months. Four years later, Infinimmune has raised close to $90 million, built its own pi...
S4, E7: From the Archive – Revisiting Synchron and Brain-Computer Interfaces, 2 Years Later
July 01, 2026
In this July summer episode, we slow things down again and revisit a conversation from the Raising Biotech archive. Today's episode is a replay from November 2023, featuring Synchron, a company developing implantable brain-computer interfaces (BCIs) to restore communication and digital independence for people living with severe paralysis. At the time, brain-computer interfaces sat somewhere between science fiction and early clinical reality. There were only a handful of companies pursuing i...
S4, E6: Investor Spotlight: From Cancer Physician to Biotech Investor, with Dr Jakob Dupont of Sofinnova Investments
June 03, 2026
In this special Investor Spotlight edition of Raising Biotech, Surani sits down with Dr. Jakob Dupont, Executive Partner at Sofinnova Investments, to explore one of the most unusual career trajectories in biotech. Before becoming a venture investor, Dupont spent decades as a physician, cancer researcher, biotech executive, and drug developer, helping bring therapies from the laboratory all the way to patients. From Memorial Sloan Kettering to Genentech, Roche, OncoMed, Gossamer Bio and Atara ...
Boba & Biotech · High booking difficulty · 100 - 1,000 listeners
Raising Biotech is hosted by Surani Fernando. Its publicly listed emails are raisingbiotech@gmail.com and sfernando.journalist@gmail.com. For guest bookings, the host or producer is usually the best person to reach. Podseeker helps you find direct host and producer contacts and pitch from your own inbox.
The publicly listed emails for Raising Biotech: raisingbiotech@gmail.com and sfernando.journalist@gmail.com.
Podseeker estimates Raising Biotech reaches 100 to 1,000 listeners per episode. Only the publisher has exact numbers.
Raising Biotech typically books industry leaders. Typical guest background: Founders, CEOs, investors (e.g., venture investors, investment partners, CBOs at investment firms), and recognized scientific/medical experts (e.g., university professors/clinical researchers) with direct experience in biotech company building, clinical-stage development, funding/strategy, or regulatory/implementation of therapeutics. Common among recent guests: Leadership roles at biotech companies (CEO/founder); Leadership roles in investment firms focused on biotech; Academic/professional recognition in relevant neuroscience/pharmacology or drug development. Recent guests include Dr Jakob Dupont, Prof David Nutt, and Kabir Nath.
Medium. Guests usually need solid credentials in the topic and an idea that fits the show.
Recent episodes cover Biotechnology, Venture Capital, Drug Development, Healthcare, and Clinical Trials. Pitch an idea tied to one of these topics and mention a recent episode.
Publicly listed emails
raisingbiotech@gmail.com
sfernando.journalist@gmail.com
Looking for the right person? Join Podseeker to find direct host and producer contacts and manage your podcast outreach.
Try us risk free with a FREE 3 days trial.
Join hundreds of PR teams using Podseeker to pitch and land bookings